For universal access to quality TB care for all patients RNTCP initiated over 12.8 million patients on treatment It has initiated treatment of multi drug resistant-TB since 2007 Having achieved the global objectives of a new 70 per cent in case-detection and a treatment success rate of 85 per cent for the last three consecutive years, the Revised National Tuberculosis Control Programme (RNTCP) is being further revised with the objective of universal access...

Appreciating the efforts of the government in containing polio and HIV, software czar and philanthropist Bill Gates on Tuesday discussed issues relating to immunisation and pentavalent vaccine production with Union Health Minister Ghulam Nabi Azad here. Mr. Gates and his wife Melinda called on Mr. Azad and discussed matters relating to the immunisation programme, pentavalent vaccine, polio vaccination efforts, HIV control and capacity building, senior officials said. The Microsoft founder appreciated the...

The United Nations health agency today released its first ever list of the most vital medicines for saving the lives of mothers and children, and stressed the need to ensure their availability in developing countries. The list of the top 30 medicines includes oxytocin, a drug used to treat severe bleeding after childbirth, the leading cause of maternal death, as well as simple antibiotics to treat pneumonia, which kills an estimated...

India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....

The government today said multi national companies (MNCs) are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment. In a written reply to the Lok Sabha, Minister of State for Commerce and Industry Jyotiraditya Scindia said: "A concerted campaign against India pharma industry has been launched by MNCs whose interests are getting adversely impacted due to increasing...